Global Biosimulation Market
The global Biosimulation market was valued at USD 3,543.00 million in 2021 which expected to reach USD 9,035.30 million by 2027 at a CAGR 14.31% from 2021-2027.
Biosimulation is a technique that uses computer algorithms to simulate biological processes. Biosimulation has numerous applications in the realm of drug discovery and development. It is a predictive tool, and biosimulation is used to forecast the outcomes of current trials connected to the discovery and development of new medications.
The drug discovery and development process is expensive, and the failure of a therapeutic molecule in the late stages of drug development results in a massive waste of time, money, and other resources. As a result, a predictive tool is required to aid in predicting the future results of drug development through simulation of the biological processes involved.
Market Drivers
Growth in the biologics and biosimilar market.
The increasing pressure to lower healthcare costs, rising demand for biosimilars due to their cost-effectiveness, rising prevalence of various diseases, rising number of off-patent drugs, positive results in ongoing clinical trials, and rising demand for biosimilars in various therapeutic applications such as rheumatoid arthritis and blood disorders are some of the main factors driving growth in the global biosimilars market. Pharmaceutical companies are attempting to identify new uses for their current medications because research and development of new chemical entities has not been very successful.
Biosimulation technologies are utilized to confirm the theory of employing the pharmaceuticals for a new indication or condition because toxicity and other important drug safety criteria have already been examined.
Market Restraints
The many features of biological processes are captured and processed by biosimulation using a variety of models, tools, and languages. The development, reuse, composition, and merging of many, complex biosimulation models is not supported by the present modelling techniques since they do not capture the semantic underpinnings of these models. The use of in silico or biosimulation technology in the drug research or development process has not yet been standardized by the governing organizations.
The computational capacity of biomedical researchers has increased recently, enabling them to create and maintain sophisticated biosimulation systems. However, researchers find it more challenging to communicate, manage, and change their models as their simulations and models become more complicated.
Impact of COVID-19
The biosimulation market was greatly influenced by the COVID-19 pandemic in the healthcare sector. The demand for biosimulation software and services was sparked by the need to quickly evaluate and create COVID-19 vaccine candidates.
In a study from April 2021 that was published in the National Center for Biotechnology Information, in silico modelling utilising the biosimulation tool BIOiSIM was done using preclinical in vitro and in vivo datasets that were well-known. The purpose of this study was to hasten COVID-19 medication development and the repurposing of therapies used for pulmonary hypertension.
The increase in such research suggested a favorable effect on market growth brought on by the increased need for expedited COVID-19 drug development.
Market Segmentation
The Global Biosimulation Market is segmented into Application, Product, Distribution Channel and Growing System. By Application such as Drug Development, Drug Discovery, Others. By Product such as Software, Services. By End User such as Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, Academic Research Institutions.
Regional Analysis
Global Biosimulation Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The market in Europe is projected to dominate the Global Biosimulation market due to an increase in the Pharmaceutical & Biotechnology Companies and CROs segment in the region. This growth is attributable to the existence of significant companies, increased healthcare digitization, and the rising prevalence of chronic health concerns. Furthermore, the use of in-silico models during regulatory policy enforcement to ensure high patient safety and treatment standards is adding to regional market growth.
Key Players
Various key players are listed in this report such as Certara, USA, Dassault Systemes, Advanced Chemistry Development, Simulation Plus, Schrodinger, Inc, Chemical Computing Group ULC, Physiomics Plc, Rosa & Co. LLC, BioSimulation Consulting Inc, Genedata AG
Market Taxonomy
By Application
By Product
By End User
By Region
Key Questions Addressed by the Report
Global Biosimulation Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Biosimulation Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Biosimulation Market, By Application
5.1 Y-o-Y Growth Comparison, By Application
5.2 Global Biosimulation Market Share Analysis, By Application
5.3 Global Biosimulation Market Size and Forecast, By Application
5.3.1 Drug Development
5.3.2 Drug Discovery
5.3.3 Others
6 Global Biosimulation Market, By Product
6.1 Y-o-Y Growth Comparison, By Product
6.2 Global Biosimulation Market Share Analysis, By Product
6.3 Global Biosimulation Market Size and Forecast, By Product
6.3.1 Software
6.3.2 Services
6.3.2.1 In-house Services
6.3.2.2 Contract Services
7 Global Biosimulation Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Biosimulation Market Share Analysis, By End User
7.3 Global Biosimulation Market Size and Forecast, By End User
7.3.1 Pharmaceutical & Biotechnology Companies
7.3.2 CROs
7.3.3 Regulatory Authorities
7.3.4 Academic Research Institutions
8 Global Biosimulation Market, By Region
8.1 Global Biosimulation Market Share Analysis, By Region
8.2 Global Biosimulation Market Share Analysis, By Region
8.3 Global Biosimulation Market Size and Forecast, By Region
9 North America Biosimulation Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 North America Biosimulation Market Share Analysis, By Application
9.3 North America Biosimulation Market Size and Forecast, By Product
9.4 North America Biosimulation Market Size and Forecast, By End User
9.6 North America Biosimulation Market Size and Forecast, By Country
9.7.1 U.S.
9.7.2 Canada
9.7.3 Mexico
10 Europe Biosimulation Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Europe Biosimulation Market Share Analysis, By Application
10.3 Europe Biosimulation Market Size and Forecast, By Product
10.4 Europe Biosimulation Market Size and Forecast, By End User
10.6 Europe Biosimulation Market Size and Forecast, By Country
10.6.1 Germany
10.6.2 France
10.6.3 UK
10.6.4. Rest of Europe
11 Asia Pacific Biosimulation Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Asia Pacific Biosimulation Market Share Analysis, By Application
11.3 Asia Pacific Biosimulation Market Size and Forecast, By Product
11.4 Asia Pacific Biosimulation Market Size and Forecast, By End User
11.6 Asia Pacific Biosimulation Market Size and Forecast, By Country
11.6.1 China
11.7.2 Japan
11.8.3 India
11.8.4. Rest of Asia Pacific
12 Latin America Biosimulation Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Latin America Biosimulation Market Share Analysis, By Application
12.3 Latin America Biosimulation Market Size and Forecast, By Product
12.4 Latin America Biosimulation Market Size and Forecast, By End User
12.6 Latin America Biosimulation Market Size and Forecast, Country
12.7.1. Brazil
12.8.2. Rest of Latin America
13 Middle East Biosimulation Market Analysis and Forecast (2021-2027)
13.1 Introduction
13.2 Middle East Biosimulation Market Share Analysis, By Application
13.3 Middle East Biosimulation Market Size and Forecast, By Product
13.4 Middle East Biosimulation Market Size and Forecast, By End User
13.6 Middle East Biosimulation Market Size and Forecast, By Country
13.7.1. Saudi Arabia
13.8.2. UAE
13.8.3. Egypt
13.9.4. Kuwait
13.10.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Certara, USA
15.1.1 Overview
15.1.2 Applications
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Dassault Systemes
15.2.1 Overview
15.2.2 Applications
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Advanced Chemistry Development
15.3.1 Overview
15.3.2 Applications
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Simulation Plus
15.4.1 Overview
15.4.2 Applications
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Schrodinger, Inc
15.5.1 Overview
15.5.2 Applications
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Chemical Computing Group ULC
15.6.1 Overview
15.6.2 Applications
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Physiomics Plc
15.7.1 Overview
15.7.2 Applications
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Rosa & Co. LLC
15.8.1 Overview
15.8.2 Applications
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 BioSimulation Consulting Inc
15.9.1 Overview
15.9.2 Applications
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Genedata AG
15.10.1 Overview
15.10.2 Applications
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
